FKBP12-binding domain analogues of FK506 are potent, nonimmunosuppressive neurotrophic agents in vitro and promote recovery in a mouse model of Parkinson's disease

被引：40

作者：

Hamilton, GS

Huang, W

Connolly, MA

Ross, DT

Guo, H

Valentine, HL

Suzdak, PD

Steiner, JP

机构：

[1] Guilford Pharmaceuticals, Inc., Dept. of Research, Baltimore, MD 21224

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 13期

关键词：

D O I：

10.1016/S0960-894X(97)00304-1

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of simple N-(glyoxyl)pipecolate esters were synthesized as mimics of the FKBP12-binding domain portion of FK506. Compounds which were effective inhibitors of the prolyl isomerase activity of FKBP12 were extraordinarily potent neurotrophic agents in vitro, and were effective in a mouse model of Parkinson's Disease. These results suggest that FKBP12 ligands have therapeutic utility in neurodegenerative diseases. (C) 1997 Elsevier Science Ltd.

引用

页码：1785 / 1790

页数：6

共 24 条

[1] DESIGN, SYNTHESIS AND STRUCTURE OF NON-MACROCYCLIC INHIBITORS OF FKBP12, THE MAJOR BINDING-PROTEIN FOR THE IMMUNOSUPPRESSANT FK506 [J].

ARMISTEAD, DM ;

BADIA, MC ;

DEININGER, DD ;

DUFFY, JP ;

SAUNDERS, JO ;

TUNG, RD ;

THOMSON, JA ;

DECENZO, MT ;

FUTER, O ;

LIVINGSTON, DJ ;

MURCKO, MA ;

YAMASHITA, MM ;

NAVIA, MA .

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1995, 51 :522-528

[2]

BECKER JW, 1993, J BIOL CHEM, V268, P11335

[3] A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX [J].

BROWN, EJ ;

ALBERS, MW ;

SHIN, TB ;

ICHIKAWA, K ;

KEITH, CT ;

LANE, WS ;

SCHREIBER, SL .

NATURE, 1994, 369 (6483) :756-758

[4] THE IMMUNOSUPPRESSIVE AND TOXIC EFFECTS OF FK-506 ARE MECHANISTICALLY RELATED - PHARMACOLOGY OF A NOVEL ANTAGONIST OF FK-506 AND RAPAMYCIN [J].

DUMONT, FJ ;

STARUCH, MJ ;

KOPRAK, SL ;

SIEKIERKA, JJ ;

LIN, CS ;

HARRISON, R ;

SEWELL, T ;

KINDT, VM ;

BEATTIE, TR ;

WYVRATT, M ;

SIGAL, NH .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (03) :751-760

[5]

GOLD BG, 1994, RESTOR NEUROL NEUROS, V6, P287, DOI 10.3233/RNN-1994-6404

[6]

GOLD BG, 1995, J NEUROSCI, V15, P7509

[7]

HAMILTON GS, 1996, SOC NEUR ABSTR, V22

[8] STRUCTURE-ACTIVITY STUDIES OF SYNTHETIC FKBP LIGANDS AS PEPTIDYL-PROLYL ISOMERASE INHIBITORS [J].

HOLT, DA ;

KONIALIANBECK, AL ;

OH, HJ ;

YEN, HK ;

ROZAMUS, LW ;

KROG, AJ ;

ERHARD, KF ;

ORTIZ, E ;

LEVY, MA ;

BRANDT, M ;

BOSSARD, MJ ;

LUENGO, JI .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (02) :315-320

[9] DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12 [J].

HOLT, DA ;

LUENGO, JI ;

YAMASHITA, DS ;

OH, HJ ;

KONIALIAN, AL ;

YEN, HK ;

ROZAMUS, LW ;

BRANDT, M ;

BOSSARD, MJ ;

LEVY, MA ;

EGGLESTON, DS ;

LIANG, J ;

SCHULTZ, LW ;

STOUT, TJ ;

CLARDY, J .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (22) :9925-9938

[10] Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases [J].

Kay, JE .

BIOCHEMICAL JOURNAL, 1996, 314 :361-385

← 1 2 3 →